ArticleCerebral circulation - cognition and behavior2026
Editorial commentary: The usefulness of the new VasCog-2-WSO criteria for the diagnosis of vascular cognitive impairment and dementia.
Article in Cerebral circulation - cognition and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebrovascular disease has a major role in the development of dementia, contributing to cognitive and functional decline in up to 75 % of all cases, and being the predominant or only cause in 15 to 20 % of cases. The importance of prevention and disease-modifying treatments to minimise the contribution of cerebrovascular disease to dementia has never been more obvious. To maximise the impact of such measures, accurate diagnosis is essential. The VasCog-2-WSO Criteria Consortium recently published diagnostic criteria for vascular cognitive impairment and dementia (VCID), updating the VasCog criteria published in 2014. The key features, strengths and limitations of the VasCog-2-WSO criteria are outlined, which suggest that these criteria have the potential to harmonise the diagnosis of VCID internationally, and infuse new energy into the development of treatment and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.